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ABSTRACT 
BACKGROUND 
                Lateral epicondylitis is the commonest chronic disabling painful condition of 
the elbow. Elbow pain and tenderness with resisted wrist extension are common 
manifestations in lateral epicondylitis. Recent studies have suggested Autologous 
Blood injection {ABI} to be a safe and effective therapy for tennis elbow. 
OBJECTIVES OF STUDY 
To evaluate the short term and long term results of autologous blood injection 
for the treatment of refractory lateral epicondylitis. To provide pain-free elbow. 
STUDY DESIGN 
  PROSPECTIVE STUDY. 
MATERIALS AND METHODS: 
             120 Patients over a period of 2 years from August  2016 to July  2018  with 
refractory lateral epicondylitis attending Department of Orthopaedics & Traumatology 
OPD at Govt Rajaji hospital, Madurai  will be taken up for study after obtaining 
consent. All the patients selected for study will be examined according to protocol, 
associated injuries should be noted and clinical and lab investigations carried out in 
order to get fitness for procedure.  Consent of the patient will be taken for procedure. 
Patients were taken 3 ml of autologous blood drawn from contra lateral upper limb 
mixed with 1 ml of 0.5 % bupivacine. Patient in supine with elbow is flexed to 90 degree 
with palm facing down. Under aspetic precautions needle is introduced proximal to 
lateral epicondyle along the supracondylar ridge into the tendon at the maximum point 
of tenderness. Pain(VAS) and NIRSCL Score& Hand grip will be assessed on follow-
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up. Patient’s clinical improvement will be assessed using NIRSCL SCORE & manual 
Hand grip clinically during every follow-up. Patient will be followed till good 
functional outcome is achieved clinically.  
RESULTS 
To our knowledge this study, perhaps the large group of  120 patients having 
refractory lateral epicondylitis  participating with follow-up of 1 year. The evaluation 
of the patients was carried out by the degree of the pain and the amount of disability in 
the pre injection phase, and at subsequent outpatient visits at 1st week, 1,3, 6,  and 12 
months (the final follow up). The degree of pain was assessed by employing the Visual 
Analogue scale (VAS), the degree of disability was evaluated by Nirschl staging & 
functionally by Hand grip. Pre-injection  average pain(VAS) score was 8.7 (range, 6-
10), the average Nirschl stage was 6.4 (range, 5-7) & the Hand grip was 28.8(range 20-
50%) . After autologous blood injections the average pain score decreased from 8.7 to 
0.19, the average Nirschl stage decreased from 6.4 to 0.1 & Hand grip from 28.8 to 97.3 
% at 1 year follow-up . Most number of patients dramatically improved with single 
injection. Only 3 patients(2.5 %) required another second episode of injection, those 3 
patients also having some amount of improvement in VAS score, Nirschl score & Hand 
grip from pre-injection & first time ABI, second injection for achieving  maximum 
improvement in functional & pain score. The significant maximal benefit was reached 
at an average of 5 weeks (range, 1 wk. to 10 wk.) after injection.  
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